Related Experiment Video
Updated: May 30, 2026

Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo
Published on: September 28, 2022
Plant-derived antigens as mucosal vaccines
H S Mason1, M M Herbst-Kralovetz
1Center for Infectious Diseases and Vaccinology, Biodesign Institute, Arizona State University, Tempe, AZ 85287, USA. hugh.mason@asu.edu
Plant-based vaccines offer mucosal delivery advantages for humans and animals. Purified antigens with adjuvants show promise, overcoming challenges of oral delivery for effective immunization.
Area of Science:
- Biotechnology
- Vaccinology
- Plant molecular biology
Background:
- Recombinant subunit vaccines produced in plants have advanced significantly over the past two decades.
- Plants offer unique advantages for developing vaccines, particularly for mucosal delivery in humans and animals.
Purpose of the Study:
- To review methods for recombinant protein expression in plants for vaccine development.
- To describe progress in human and animal vaccines utilizing mucosal delivery routes.
- To discuss challenges and potential solutions for plant-based vaccine efficacy.
Main Methods:
- Expression of recombinant antigens in stably and transiently transformed plants.
- Development of viral vectors, including virus-like particles, for antigen expression.
- Utilizing pattern recognition receptor agonists as adjuvants to enhance immune responses.
Main Results:
- Demonstrated antibody production in humans and animals following mucosal administration of plant-derived antigens.
- Achieved protection against pathogen challenge in some animal studies.
- Identified low antigen content and gut instability as key hurdles for oral delivery.
Conclusions:
- Intranasal delivery of purified plant-derived antigens, especially with adjuvants, is a promising strategy for effective immunization.
- Plant-based vaccine technology continues to evolve, with ongoing research addressing efficacy and regulatory considerations.
- Further development is needed to optimize antigen stability and delivery for widespread application.
More Related Videos
Related Concept Videos
Microorganisms in Medicine and Therapeutics
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Antigens Involved in Adaptive Immunity
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
Vaccines
Vaccinations
Vaccine Production

